ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

January 10, 1997

Gastrointestinal SPORE To Be Recompeted

June 23, 1995

MRI Predicts If Chemo Working In Preoperative Therapy

February 25, 2005

O’Leary Leads RPCI’s OR;

February 8, 2002

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001

NCI Deputy Barker Hits FDA, Calls for New Incentives for Pharmaceutical Industry; Barker Co-Founded Dietary Supplements Firm

May 30, 2003